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Topoisomerase II Is a 
Mitotic Chromosome 
Structural 
Scaffolds 
Component of 
WILLIAM C. EARNSHAW,* BRIAN HALLIGAN,* CAROL A. COOKE,* 
MARGARETE M. S. HECK,* and LEROY F. LIU* 
*Department of Cell Biology and Anatomy, and *Department of Biological Chemistry, Johns Hopkins 
School of Medicine, Baltimore, Maryland 21205 
ABSTRACT We have obtained a polyclonal antibody that recognizes a major polypeptide 
component of chicken mitotic chromosome scaffolds. This polypeptide migrates in SDS PAGE 
with Mr 170,000. Indirect immunofluorescence and subcellular fractionation experiments 
confirm that it is present in both mitotic chromosomes and interphase nuclei. Two lines of 
evidence suggest that this protein is DNA topoisomerase II, an abundant nuclear enzyme that 
controls DNA topological states: anti-scaffold antibody inhibits the strand-passing activity of 
DNA topoisomerase II; and both anti-scaffold antibody and an independent antibody raised 
against purified bovine topoisomerase II recognize identical partial proteolysis fragments of 
the 170,000-mol-wt scaffold protein in immunoblots. Our results suggest that topoisomerase 
II may be an enzyme that is also a structural protein of interphase nuclei and mitotic 
chromosomes. 
It has been known for many years that the chromatin fiber of 
both meiotic (1-4) and mitotic (5) chromosomes is folded 
into loops. In 1977 and 1978, Laemmli and co-workers (6-8) 
proposed that in mitotic hromosomes these loops are formed 
as a result of interactions between the nucleohistone fiber and 
a subgroup of chromosomal nonhistone proteins. A residual 
structure thought to be enriched in these nonhistone proteins 
was isolated by extraction of nuclease-digested chromosomes 
under conditions that solubilized >90% of the chromosomal 
proteins, including all of the histones (9). Because it retained 
the size and approximate shape of the mitotic chromosome, 
this residual structure, was termed the "chromosome scaf- 
fold." More recent studies have shown that the scaffold frac- 
tion is greatly enriched in two high molecular weight polypep- 
tides, Sc-I (170,000 mol wt) and Sc-2 (135,000 mol wt; see 
reference 10). 
The existence of a discrete scaffold substructure in intact 
mitotic chromosomes remains a subject of some debate. The 
isolated residual scaffold comprises only 3-4% of the chro- 
mosome mass (10). Therefore, it is not surprising that direct 
inspection of whole mounts (11, 12) or thin sections (13) of 
intact chromosomes does not permit ready visualization of a 
scaffold substructure, although under certain conditions axial 
structures can be seen (14). Localization of scaffold compo- 
nents in intact chromosomes has been forced to wait for the 
availability of anti-scaffold antibodies (15). 
1706 
Results from a number of laboratories suggestthat the 
chromatin fiber of interphase chromosomes is also topologi- 
cally constrained in loops (16-22). ILcorre~t, this model 
implies that DNA topoisomerases might be required for the 
termination of replication. For example, the final stages of 
SV40 replication involve production of catenated dimers (23, 
24). In the absence of nicks, such strucures can only be 
separated by a type II DNA topoisomerase. This class of 
enzyme changes the linking number of circular DNA mole- 
cules in steps of two, in an ATP-dependent reaction that 
proceeds via production of protein-linked double strand DNA 
breaks (recently reviewed in reference 25). If cellular chro- 
mosomes are constrained in closed loops, then topoisomerase 
1I might play an essential role in termination of replication 
and for chromosome segregation. Analysis of conditional 
lethal topoisomerase II mutants in the unrelated yeasts Sac- 
charomyces cerevisiae (26) and Schizosaccharomyces pornbe 
(27) confirms that the enzyme is required for chromosome 
segregation, at least in lower eucaryotes. 
We describe experiments performed with an antiserum 
against a 170,000-mol-wt chromosome scaffold polypeptide 
from chicken cells. Two independent lines of evidence suggest 
that this scaffold protein is DNA topoisomerase II. These are 
inhibition of topoisomerase function by anti-scaffold anti- 
body, and comparison f binding of anti-scaffold and anti- 
topoisomerase II antibodies to partial peptides derived from. 
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the scaffold protein I (Sc-1)~ polypeptide. Availability of the 
anti-topoisomerase antibody permits the first quantitative 
analysis of the scaffold isolation procedure. Topoisomerase II 
is recovered at high yield (-70%) in chromosome scaffolds 
made at either high or low ionic strength. These results have 
important implications for the control of expression of chro- 
matin domains and for chromosome segregation. 
MATERIALS AND METHODS 
Cell Culture: MSB-I cells, the gift of H. Weintraub (Hutchinson 
Cancer Center, Seattle, WA), were grown in RPMI-1640 (Gibco Laboratories, 
Grand Island, NY) + 5% Hyclone fetal calf serum (Sterile Systems, Logan, 
Utah; later replaced with 5% iron-suplemented calf serum from the same 
supplier). Chicken tumor cells, line 249, originally from the laboratory of M. 
Wigler (Cold Spring Harbor), were the gift of D. Cleveland (Johns Hopkins 
School of Medicine). These and primary cultures of chick embryo fibroblasts 
(28) were grown in Eagle's minimal essential medium with nonessential amino 
acids (Gibco Laboratories) plus 10% fetal calf serum and 1% chicken serum. 
Production of Antibody to Guinea Pig Chicken Scaffold 
Protein 1: 80 liters of MSB-1 chicken lymphoblastoid cells were grown in 
spinner culture in batches ranging from1.5-12 liters. Cells were accumulated 
in C-metaphase byincubation in the presence of 0.1 ~g/ml colcemid for 12- 
16 h. Chromosomes were isolated by a minor modification of the polyamine 
method of Lewis and Laemmli (10). We modified the procedure by replacing 
the 40-ml sucrose gradient with a 16-ml 15-60% gradient ove  a 10-ml shelf o
80% sucrose. This procedure gives a chromosome r covery of ~25% (Table I).
Chromosomes from each preparation were frozen on N2(l). 
All solutions for chromosome and interphase nuclear isolations were pre- 
pared fresh from 10x stocks, and the protease inhibitors Trasylol (Mobay 
Chemical Co., FBA Pharmaceuticals, New York), and phenylmethylsulphonyl 
fluoride (Sigma Chemical Co., St. Louis, MO) were added to l0 Kallikrein 
inhibitor units/ml and 0.1 mM, respectively, immediately before use. 
Scaffolds were prepared from 95 mg of chromosomes by standard procedures 
using 2 M NaCl to extract the bulk of the chromosomal protein (9, 14). The 
scaffolds were resuspended in SDS PAGE sample buffer (10) and lectropho- 
resed in two preparative SDS polyacrylamide gels. The gels were washed with 
water to remove SDS and stained with 0.1% Coomassie Blue in Ix running 
buffer minus SDS (L. Gerace, personal communication). Bands to be u ed as 
antigen were excised, homogenized in water with a Potter-Elvehjem motor 
driven homogenizer, and frozen in N2(I). Guinea pigs were injected with ~ 100 
#g of protein in acrylamide plus complete Freund's adjuvant (Difco Laborato- 
ties, Inc., Detroit, M1), given a booster injection o f -50  ~g (in incomplete 
Freund's adjuvant) at 30 d, and bled 14 d later by cardiac punture. 
Affinity-eluted antibody was prepared from preparative nitrocellulose blots 
of SDS polyacrylamide gels, as described previously (29). 
Production of Antibody to Bovine Topoisomerase II: The 
first large scale isolation of topoisomerase II from a mammalian source, and 
preparation of antibody recognizing the purified enzyme are described in deta l 
in reference 30. Important steps in the enzyme purification included the 
following: extraction f nuclei under conditions in which the c romosome 
scaffold is sol ubilized (presence of B-mercaptoethanol [10]); polymin P precip- 
itation of chromatin; ammonium sulphate precipitation; andchromatography 
on BioRex 70, hydroxylapatite, and blue agarose. This procedure yielded a 
1,300-fold purification of the enzyme, which migrated in SDS PAGE as a 
doublet of Mr 125,000 and 140,000 (30). Both species yielded identical 2- 
dimensional tryptic maps. A rabbit was injected with a band excised from an 
SDS gel. Serum from this immunized animal recognizes a single polypeptide 
of Mr ~ 180,000 in immunoblots of whole cell lysates from calf, human, 
monkey, hamster (30), and chicken (B. Halligan, unpublished observations). 
Gel Electrophoresis: Gel recipes were as previously published (10). 
4x sample buffer was 0.125 M trizma base, 0.96 M glycine, 21% glycerol, 2.5% 
SDS, 0.25% bromphenol blue, and 0.5 M 2-mercaptoethanol. l x sample buffer 
was 0.16 M Tris:HCl, pH 8.8, 16% sucrose, 2.2 mM EDTA, 3.3% SDS, 0.01% 
bromphenol b ue, and 22 mM dithiothreitol. 
Immunoblotting: The protocol for these experiments has been de- 
scribed previously (29, 31). 
Immunofluorescence: Indirectimmunofluorescence was performed 
I Abbreviations used in this paper: CENP-A and CENP-B, human 
centromere proteins of Mr 17,000 and 80,000, respectively; Sc-1 and 
cSc-l, human and chicken scaffold protein 1, respectively; TCA, 
trichloroacetic acid. 
as previously described (31), except that hepatoma and chick embryo fibroblast 
cultures were grown on polylysine-coated coverslips. Before processing for 
immunofluorescence, thecoverslips were centrifuged at 1,000 g for 2 rain to 
increase adherence of mitotic cells. Subsequent processing was as described 
previously (31). Rhodamine-conjugated anti-guinea pig IgG w s obtained from 
Capp¢l Laboratories (Cochranville, PA). 
Bookkeeping Experiments: Two methods were used to determine 
the percentage of total cellular chicken scaffold protein 1 (cSc-1) found in 
chromosomes and nuclei. Procedure a involved spotting solutions containing 
antigen onto nitrocellulose strips and processing these with iodinated protein 
A as for normal immunoblots (31). After drying, the strips were sliced up and 
counted in a g mma counter. In procedure b, aliquots of samples were subjected 
to SDS PAGE as described previously (10). The proteins were then transferred 
to nitrocellulose paper by electroblotting (32), and processed in the standard 
way with iodinated protein A. The blots were used to expose preflashed films 
at -70°C (33). Films were scanned with a densitometer (Hoefer Scientific 
Instruments, San Francisco, CA), and the amount of material in the cSc- 1 band 
determined by cutting out and weighing the peak. As shown in Table 1, 
procedures a and b give comparable results. 
The procedure used forchromosome isolation was as follows: 8 h before the 
addition of colcemid to the growing culture, [3H]thymidine was added to 0.12 
#Ci/ml. The colcemid block was as described above. Next morning, 125 ml of 
culture was centrifuged an  resuspended toswell in 50 ml of RSB buffer (10 
mM Tris:HCl, pH 7.4, 10 mM NaC1, 5 mM MgCI2). After 5 min at room 
temperature (during which time the mitotic index was measured), the cells were 
centrifuged at 800 g for 3 min. The swollen cell pellet was vigorously resus- 
pended in 10 ml lysis buffer (15 mM Tris:HCl, pH 7.4, 2 mM K-EDTA, 80 
mM KCI, 0.2 mM Spermine, 0.5 mM Spermidine, 0.1% digitonin [10]), and 
the cells disrupted with 10 strokes of a Dounce homogenizer. 50 #1 of homog- 
enate was removed and stored at 4°C for subsequent trichloroacetic acid (TCA) 
precipitation. Two 0.5-ml aliquots of lysate were removed an  processed for 
electrophoresis as follows: CaCI2 was added to 3 mM and micrococcal nuclease 
(Worthington Biochemical Corp., Freehold, N J) to 40 /zg,,'ml. The digestion 
was allowed to proceed 20 rain t 4°C and then terminated in one of two ways. 
To one aliquot was added % volume of 4x SDS PAGE sample buffer. This 
aliquot was then extensively sonicated and boiled, yielding a sample for 
determination of total antigen. After nuclease digestion, the other aliquot was 
centrifuged at 16,000 g for 10 rain and then resuspended in 0.5 ml Ix SDS 
PAGE sample buffer. This was then sonicated and boiled, yielding the sample 
for determination f total insoluble antigen. During the processing of the above 
samples, the rest of the homogenate was processed for chromosome isolation 
as described by Lewis and Laemmli (10). The final chromosome p llet was 
resuspended in 0.5 ml of 5 mM Tris:HCl, pH 7.4, 2 mM KC1, 0.25 mM 
spermidine, 0.1% digitonin (10), The chromosomes were then processed for 
determination of 3H and total insoluble antigen as described above. 
The chromosome yield was calculated as the percent of acid-insoluble 3H 
recovered, taking to account he mitotic index, since this procedure separates 
chromosomes from nuclei. The TCA precipitation was performed by standard 
methods, with nucleic acid being precipitated by 10% TCA in the presence of 
1.5% Na-pyrophosphate and 0.1% bovine serum albumin (BSA) as carder. 
Precipitates, collected on GF/C (Whatman Chemical Separation Inc., Clifton, 
N J) filters were counted in Aquasol-2 after drying. The f al yield of cSc-l was 
measured by either procedure a or b as described above. The final yields were 
normalized by taking into account thechromosome yield calculated above, th  
relative amounts of original culture loaded p r lane (0.15 ml for homogenate, 
3.9ml for chromosomes), and (where applicable) the width of the gel lanes. 
The amount of cSc-I in interphase nuclei wascalculated as follows: Cells 
were grown overnight in he presence of [3H]thymidine as above, but no 
colce id was added. Next morning, cells (50-ml culture) were centrifuged at 
800 g for 3 min and resuspended for hypotonic swelling in RSB buffer (see two 
paragraphs above) for 5 min at room temperature. They were then centrifuged 
at 800 g for 3 rain and resuspended in 4 ml lysis buffer (same as chromosome 
lysis buffer above, but plus 20% percoll [modified from reference 34]). Cell 
disruption was accomplished by vigorous Dounce homogenization (20x). An 
aliquot was taken as above for TCA precipitation, 0.5 ml removed for mea- 
surement of antigen, and the rest of the lysate centrifuged at 250 g for 5 min. 
The supernatant was removed by aspiration, and the pellet of nuclei resus- 
pended in 4 ml lysis buffer. After a second centrifugation, the nuclear pellet 
was resuspended in a volume equal to that of the original homogenate, SDS 
added to 0.1%, the sample lightly sonicated, an aliquot taken for TCA precip- 
itation, and the remainder processed for detection of antigen by procedure a 
described above. 
Enzyme Assays: Mitotic chromosomes were prepared from 500 ml of 
colcemid-arrested MSB-I chicken lymphoblastoid cells by gentle differential 
centrifugation (15). Topoisomerase II extracts were prepared from the chro- 
mosomes by the method f Miller et al. (35). Extracts were incubated with 
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antisera (all used at a dilution of 1:50) for 1 h at 4°C with gentle agitation. 
Immune complexes were adsorbed by addition of fixed Staphylococcus aureus 
to ~0.6% (wt/vol). This suspension was incubated for 1 h at 4"C with agitation, 
and the immune complexes subsequently r moved by centrifugation at 16,000 
g for 5 min. Assay conditions for topoisomerase l (relaxation ofsupercoiled 
pBR322 DNA [36]) and topoisomerase II (unknotting ofphage P4 DNA [37]) 
were as previously described, except that he incubation was done at 37"C for 
2h. 
RESULTS 
Production of Antibodies to a Polypeptide from 
Chicken Chromosome Scaffolds 
Fig. 1 shows the protein composition of mitotic chromo- 
somes and chromosome scaffolds isolated from colcemid- 
blocked chicken cells (line MSB-1). Chromosomes (Fig. 1 b) 
were isolated by the polyamine method of Lewis and Laemmli 
(10). Nonhistone scaffolds isolated from these chromosomes 
after digestion with micrococcal nuclease and subsequent 
extraction with 2 M NaCl (9) are shown in Fig. 1 c. Chromo- 
somal proteins olubilized by the extraction are shown in Fig. 
1 d. The protein composition of chicken chromosome scaf- 
folds is similar to that of human scaffolds, as described by 
Lewis and Laemmli (10). Scaffolds of identical protein com- 
position were obtained if a low ionic strength polyanion 
extraction procedure (9, 14) was used in place of 2 M NaC1 
(data not shown). 
A guinea pig immunized with a high molecular weight 
polypeptide from chicken chromosome scaffolds (indicated 
by arrows in Fig. 1) produced antibodies that bind to a single 
band (Mr 170,000) on nitrocellulose blots of an SDS PAGE 
of whole cells (Fig. 2 b). This is the antigen we refer to as cSc- 
1. These antibodies bind to cSc-1 and a number of smaller 
FIGURE 1 SD5 PAGE of chicken 
chromosomes and nonhistone scaf- 
folds isolated from them. Lane a, 
marker proteins myosin (200 kD), ~- 
galactosidase (116 kD), phosphoryl- 
ase b (95 kD), bovine serum albu- 
min (68 kD), catalase (60 kD), actin 
(43 kD), aldolase (40 kD), carbonic 
anhydrase (29 kD), and beta-lacto- 
globulin (18.4 kD). Lane b, isolated 
chromosomes. Lane c, chromo- 
some scaffolds isolated after 2 M 
NaCI treatment. Lane d, proteins 
extracted from chromosomes by 
the 2 M NaCl treatment. The pro- 
teins were electrophoresed in a 
10% polyacrylamide gel (10) and 
visualized by staining with Coomas- 
sie Blue. The profile of scaffolds 
isolated after extraction with dex- 
tran sulfate and heparin (9) was 
identical to that in lane c; however, 
patterns of the proteins extracted 
by the polyanion procedure were 
difficult o obtain as the polyanions 
interfere with the mobility of the 
proteins in the gel lane. Several 
prominent scaffold proteins are in- 
dicated by dots between lanes b 
and c. Major extracted proteins are 
shown by dots next to lane d. The 
position of cSc-1 is indicated by 
arrows, 
FIGURE 2 Immunoblots of cellular and chromosomal proteins 
probed with anti-cSc-1. Bound antibody was detected by autora- 
diography after reaction with 12Sl-protein A. Lane a, mitotic cells 
centrifuged and resuspended in boiling SDS PAGE sample buffer; 
Coomassie Blue stain. Lane b, parallel gel lane probed with anti- 
cSc-1. In all subsequent lanes the antigen mixture came from 
isolated mitotic chromosomes and the antibodies used to probe 
the blots were as follows: (lane c) whole serum anti-cSc-1; (lane d)
preimmune serum; (lane ) anti-cSc-1 affinity eluted from the cSc- 
1 band of a preparative immunoblot (indicated to the right of lane 
f and marked m); and (lane f) anti-fragments affinity eluted from 
the indicated region (marked f) of a preparative immunoblot. Whole 
serum was used at a dilution of 1:500. Affinity-eluted antibody 
fractions were used at a dilution of 1:20. For a Coomassie Blue- 
stained view of the antigen mixtures in lanes c-f see Fig. 1 b. 
peptides present in isolated chicken chromosomes (Fig. 2 c). 
Preimmune serum did not bind to any chromosomal proteins 
(Fig. 2 d). The smaller peptides appear when cells are homog- 
enized in the presence of detergent, and co-purify with chro- 
mosomes. Antibody fractions that had been affinity-eluted 
from either cSc-1 or from the smaller peptides gave identical 
patterns when used to reprobe blots of total chromosomal 
proteins (Fig. 2, e and f).  This, together with the observation 
of a single antigenic species in boiled whole cell extracts (Fig. 
2 b), suggests that the smaller peptides are proteolytic frag- 
ments derived from cSc- 1. 
Evidence That the Scaffold Protein cSc-1 Is 
Topoisomerase II 
Both cSc-1 and topoisomerase II isolated from a number 
of species, migrate in SDS PAGE with Mr 170,000 (30, 35). 
The following experiments uggest hat cSc-1 is, in fact, 
topoisomerase II. 
First, both guinea pig anti-cSc-1 and rabbit anti-topoisom- 
erase II (prepared against enzyme purified to homogeneity 
from calf thymus [30]) bind to identical adders of polypep- 
tides on immunoblots ofchicken chromosomes and scaffolds 
(Fig. 3, b and c). The major immunoreactive polypeptides 
that migrate ahead of cSc-1 have apparent Mr 126,000, 
117,000, 106,000, 98,000, 91,000, and 81,000, These are 
presumed to be proteolytic fragments of cSc-I (preceding 
1 708 THE JOURNAL OF CELL  BIOLOGY , VOLUME 100, 1985 
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section). On overexposed autoradiographs at least nine addi- 
tional bands (corresponding to smaller fragments) are recog- 
nized by both sera. Neither preimmune serum (Fig. 3 a) nor 
guinea pig sera raised against other high molecular weight 
chromosome scaffold components bind to any of these bands 
(W. C. Earnshaw, unpublished observations). We therefore 
conclude that both antisera recognize specific epitopes that 
FIGURE 3 Topoisomerase II is found in chicken chromosome scaf- 
folds. Chromosomes and scaffolds were electrophoresed in parallel 
lanes of an SDS polyacrylamide gel, transferred to nitrocellulose, 
and probed with the following sera: (a) guinea pig preimmune 
serum; (b) guinea pig anti-cSc-1; (c) rabbit anti-topoisomerase II. 
Bound antibody was detected by incubation of the blot with ~2Sl- 
protein A, followed by autoradiography. The figure shows immu- 
noblots of isolated chromosomes (c) and chromosome scaffolds (s) 
prepared by extraction of nuclease-digested chromosomes with a 
2 M NaCI lysis mix. The positions of the fragments are indicated by 
arrowheads to the right of c. The core histones migrate with the 
dye front in this 7.5% acrylamide gel. frog., fragments. 
are present on intact cSc-I and on various fragments derived 
from it. 
The results of Fig. 3 c indicate that topoisomerase II is a 
component of chicken mitotic chromosomes and chromo- 
some scaffolds. Similar results have been obtained for HeLa 
chromosomes and scaffolds using a similar antibody (W. C. 
Earnshaw, B. Halligan, and L. F. Liu, unpublished observa- 
tions). Comparison of Fig. 3, b and c, suggests trongly that 
the scaffold antigen cSc- 1 is topoisomerase II. While our data 
do not establish unambiguously that topoisomerase II is the 
only 170,000-mol-wt antigen present i  scaffolds, this is the 
most likely interpretation f the results. 
This interpretation f our results is supported by fraction- 
ation of the proteins of isolated chromosomes by hydroxyl- 
apatite chromatography in the presence of SDS (data not 
shown). This method has been shown to effectively resolve 
high molecular weight structural proteins (38). Column frac- 
tions were analysed by SDS PAGE and immunoblotting with 
guinea pig anti-cSc-1 and rabbit anti-topoisomerase II. Both 
antibodies gave identical patterns, with 170,000-mol-wt poly- 
peptide luting at 0.52 M NaPO4, 0.1% SDS, and the frag- 
ments eluting somewhat earlier (0.46 M NaPO4, 0.1% SDS). 
Most polypeptides elute from hydroxylapatite by ~0.4 M 
NaPO, (39), and this late lution of topoisomerase II, which 
was noted previously (30), was interpreted as an indication 
that the polypeptide may be rich in hydrophobic residues. 
The identity of cSc-1 as topoisomerase II has been sup- 
ported by showing that both topoisomerases I and II can be 
extracted in active form from chicken chromosomes (Fig. 4) 
and that antibodies to cSc-1 can absorb the topoisomerase 1I 
activity from the extracts (Fig. 4, left; compare lanes E through 
H with lanes A through D, respectively). Note that topoisom- 
erase II is extracted from chromosomes under conditions in 
which the chromosome scaffold has been shown to fall apart 
(presence of 2-mercaptoethanol [ 10]). Preimmune serum had 
no effect on the activity of the enzyme (Figure 4A; compare 
lanes I through L with lanes A through D, respectively), and 
neither preimmune serum nor anti-cSc-1 had any effect on 
the activity of topoisomerase I in these xtracts (Fig, 4, right). 
Identical results were obtained ifthe rabbit anti-topoisomerase 
II antiserum was substituted for anti-cSc-1 (data not shown). 
FIGURE 4 Effect of various antisera on the activity of topoisomerases I and II in extracts prepared from isolated mitotic 
chromosomes. Extracts were exposed to (lanes A-D) no antibody, (lanes E-H) anti-cSc-1, and (lanes I-L) preimmune serum. An 
assay for topoisomerase II is shown on the left. The results of a parallel assay for topoisomerase I are shown on the right. The 
amount of extract in each reaction mixture (20 pl volume) is as follows: 1 /~1 for samples in lanes A, E, and/; 0.25 u,I for samples 
in lanes B, F, and J; 0.0625/A for samples in lanes C, G, and K; and 0~0156 pl for samples in lanes D, H, and L The smear in the 
left panel represents the heterogeneously knotted P4 DNA used to assay topoisomerase II (37). The migration of form I 
(supercoiled), form f~ (relaxed), and form Ill (linear) pBR322 DNA used in the assay for topoisomerase P (36) is indicated to the 
right of the right-hand panel. 
EARNSHAW ET AL, Topoisornerase II 1709 
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FIGURE 5 Indirect immunofluorescence using whole serum and affinity-eluted anti-cSc-1. The cells used for a-c were line 249, 
a transformed chicken cell line. d-f show a parallel experiment performed using an untransformed primary culture of chick 
embryo fibroblasts, a and d are phase-contrast images, b and e show staining of the DNA using DAPI, a nonintercalating dye that 
is brightly fluorescent when bound to DNA (58). c and f present the localization of topoisomerase II in these same cells using 
anti-cSc-1 (c, whole serum; f, affinity-eluted anti-cSc-1) and rhodamine-conjugated anti-guinea pig second antibody. Bar, 10 pm. 
Therefore, we conclude that anti-cSc-1 recognizes functional 
topoisomerase II. 
Localization of Topoisomerase II in Mitotic and 
Interphase Cells: Immunofluorescence Results 
Topoisomerase II was localized in detergent extracted cells 
by indirect immunofluorescence using anti-cSc-1 (Fig. 5). The 
enzyme was found in nuclei and mitotic chromosomes of
both transformed cell lines (Fig. 5, a-c) and untransformed 
primary cultures (Fig. 5, d-f). Little or no antigen was de- 
tected in the cytoplasm. Similar results were obtained with 
cells fixed with organic solvents. All mitotic chromosomes 
were found to label intensely (see reference 15 for details), but 
the staining of interphase nuclei varied considerably. Many 
nuclei exhibited bright punctate fluorescence, while others 
stained only weakly. 
Using MSB-1 cells separated into Gt, S, and G2 + M 
populations by a fluorescence-activated cell sorter, we found 
1 710 THE JOURNAL OF CELL BtOLOGY- VOLUME 100, 1985 
that virtually all cells that fail to stain with anti-cSc-1 have a 
Gt DNA content. Negative cells represent the following per- 
centages of the cells in each cell cycle phase: GI, 14% (71/ 
494); S, 2% (13/488); and G2 + M, 0% (0/297). Labeled cells 
from different cell cycle phases were indistinguishable with 
regard to the distribution of fluorescent antibody binding. 
We have considered two possible explanations for these 
results. The antigen may be masked (or degraded) during a 
brief portion of Gt. Alternatively, cells that are no longer 
cycling (and that would have a G~ DNA content) may no 
longer contain topoisomerase II. 
Independent confirmation that topoisomerase II is found 
in mitotic chromosomes is presented inFig. 6. This ~,figure 
shows chromosomes from chicken mitotic cells that were 
gently disrupted by centrifugation onto glass coverslips (for 
methods, see reference 15). The coverslips were then stained 
with preimmune serum (Fig. 6 b) or rabbit anti-topoisomerase 
II (Fig. 6d). Fig. 6, a and c, show the distribution of chro- 
mosomal DNA (stained with 4',6-diamidino-2-phenylindole 
dihydrochloride) in the corresponding fields. 
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FIGURE 6 Identification of topoisomerase II in mitotic chromosomes. Chicken mitotic cells were hypotonically swollen and 
centrifuged onto coverslips (15). a and c show the distribution of DNA (stained with 4',6-diamidino-2-phenylindole dihydrochlo- 
ride) in these chromosomes, b and d show the immunofluorescence obtained with (b) rabbit preimmune serum and (d) anti- 
topoisomerase II from this animal. Bar, 10 #m. 
TABLE I 
Data 
Normalized recovery of topoisomerase I1" 
Fraction Recovery of structure Total* Sedimentable j N m Procedure 
Interphase nuclei 65 -+ 11% 91 + 15% ND 20 a 
Chromosomes 16 ___ 8% 56 _ 21% ND 4 a 
Chromosomes 28 __ 9% 64 + 21% 87 + 35% 20 b 
ND, not, determined. 
* Expressed as 100 x (recovery of topoisomerase II)/(recovery of structure). 
* Calculated as 100 x (tllch,om,.uJtlltoO, where tll~h,om,.uc is the amount of topoisomerase antigen in chromosomes (tilth,ore) or nuclei (tll.u~) isolated from a known 
culture volume and tlltot is the amount of topoisomerase II in an equivalent volume of the crude whole-cell homogenate from which the structures had been 
isolated. 
t Calculated as 100 x (tllch~m,.,,Jtll~), where t l l~  is the amount of topoisomerase antigen that could be pelleted from an equivalent volume of whole-cell 
homogenate by centrifugation at 16,000 g for 10 min. 
' Number of independent determinations. 
Localization of Topoisomerase II in Mitotic and 
Interphase Cells: Cell Fractionation Experiments 
Quantitative c ll fractionation and immunoassays (Table I) 
support the conclusions ofimmunofluorescence experiments. 
Interphase nuclei, isolated bya simple differential centrifuga- 
tion procedure, in the presence of detergent, contain 91% of 
the total immunoreactive topoisomerase II present in the cells. 
Therefore, neither immunofluorescence or this cell fraction- 
ation experiment provide vidence for the existence of a pool 
of cytoplasmic topoisomerase II in interphase cells. 
Similarly, the bulk of topoisomerase II from mitotic ells is 
found in isolated chromosomes. When a total cell homog- 
enate from mitotic cells was centrifuged at 16,000 g for 10 
min (to pellet all chromosomes and nuclei), ~70% of the 
topoisomerase II (the sedimentable antigen) was recovered in
the pellet. When chromosomes were isolated from similar 
homogenates, 87% of the sedimentable antigen co-purified 
with the chromosomes through sucrose and Percoll gradients. 
This corresponds to ~60% of the total cellular pool of topoi- 
somerase II.
Not all topoisomerase II from mitotic cells co-purifies with 
chromosomes. About 30% of the antigen is apparently soluble 
in total cell homogenates. We have considered three likely 
explanations for this result. First, it is possible that the soluble 
antigen is proteolysed. However SDS PAGE/immunoblotting 
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appears to rule this out, since the ratio of 170,000-mol-wt 
polypeptide to smaller fragments i essentially identical for 
both soluble and sedimentable antigen. Alternatively, there 
may be two pools of enzyme in mitotic cells. While it is clear 
that most enzyme is associated with mitotic chromosomes, 
the remainder may either be soluble (and completely xtracted 
from cells by our immunofluorescence procedure), or it may 
be reversibly bound to chromosomes. Finally, it is possible 
that the soluble antigen is derived from chromosomes dam- 
aged by the homogenization, or from microchromosomes 
which may not sediment under the centrifugation conditions 
used. 
FIGURE 7 Chromosome scaffolds reacted with affinity-eluted anti- 
topoisomerase II (undiluted). The views shown are: (a) phase con- 
trast; (b) indirect immunofluorescence using rhodamine-coupled 
anti-guinea pig IgG. Scaffolds were produced by extraction of 
nuclease-digested chromosomes with dextran sulfate/heparin (14). 
After the extraction, aliquots were sedimented onto coverslips 
through a cushion of 0.1 M sucrose in extraction buffer. The 
remainder of the material was analyzed by SDS PAGE to confirm 
that the extraction had proceeded normally. A parallel control 
experiment with preimmune serum is not shown since both phase- 
contrast and fluorescence microscopy lacked an,/visible structures. 
The paired and single dots are scaffolds of chicken microchromo- 
somes. Note that of the scaffolds from larger chromosomes, only 
those that impact he coverslip en face will present a classical paired 
chromatid appearance. Bar, 10 ~m. 
FIGURE 8 Immunoblotting of 
proteins of isolated chromo- 
somes, chromosome scaffolds, 
and extracted fractions using 
anti-topoisomerase II. In all 
cases the samples were pre- 
pared as for those in Fig. 1, elec- 
trophoresed in a 7.5% SDS pol- 
yacrylamide gel, and immuno- 
blotted using whole serum di- 
luted 1:500. The samples elec- 
trophoresed in the lanes were 
(a) chromosomes, (b) scaffolds 
isolated after extraction of nu- 
clease digested chromosomes 
with dextran sulfate/heparin, (c) 
proteins released by the poly- 
anion extraction, (d) scaffolds 
isolated after extraction of nu- 
clease digested chromosomes 
with 2 M NaCI, and (e) proteins 
released by the 2 M NaCI ex- 
traction. The position of cSc-1 is 
indicated. 
Recovery of Topoisomerase II in Isolated 
Chromosome Scaffolds with High Yield 
Indirect immunofluorescence confirms that topoisomerase 
II is found in structures with the morphology expected for 
chicken mitotic chromosome scaffolds (Fig. 7). Even though 
isolated scaffolds are not visible under phase contrast (Fig. 
7 a), they are easily visualized using the specific antibody (Fig. 
7 b). In addition to a number of chromosome-shaped struc- 
tures, Fig. 7 b also contains numerous single and paired fluo- 
rescent dots. These are the scaffolds of microchromosomes 
(minute chromosomes that are a natural component of the 
chicken karyotype and are present in about 60 copies per cell 
[40]). 
At least 70% of the chromosomal topoisomerase II is re- 
covered in scaffold fractions prepared by extracting isolated 
chromosomes at either low or high ionic strength. In the 
experiment shown in Fig. 8, equal starting volumes of isolated 
chromosomes (Fig. 8 a), scaffolds (Fig. 8, b and d) and pro- 
teins solubilized uring the extraction (Fig. 8, c and e) were 
electrophoresed and analysed by immunoblotting. The recov- 
ery of topoisomerase II in scaffolds prepared using the 2 M 
NaC1 extraction (Fig. 8, b and c) was virtually identical to
that found using the low salt dextran sulphate:heparin extrac- 
tion (Fig. 8, d and e). In four independent experiments, the 
average values obtained were the following: NaC1 scaffolds, 
72 __. 10% recovery; and polyanion scaffolds, 72 __. 14% 
recovery. The 72% figure is a minimum value for the fraction 
of topoisomerase II associated with scaffolds, since some 
fragmentation f scaffolds occurs during the extraction pro- 
cedure (W. C. Earnshaw and U. K. Laemmli, unpublished 
observations). In addition, scaffolds of microchromosomes 
may be too small to sediment under the conditions we have 
used. 
DISCUSSION 
Until recently, the literature on eucaryotic topoisomerase lI 
has dealt largely with in vitro studies, and little is known 
about he function of the enzyme in living cells (reviewed in 
reference 25). The bacterial enzyme (DNA gyrase) has been 
implicated in replication, transcription, repair, and recombi- 
nation (reviewed in references 41, 42) and it has been assumed 
that the eucaryotic enzyme is required for similar functions. 
Recent isolation of conditional lethal topoisomerase II mu- 
tants in yeast confirms that the enzyme is essential for cell 
growth (26, 27). Furthermore, at least in synchronized cells, 
the phenotypic block appears to affect chromosome s grega- 
tion. Involvement oftopoisomerase II in segregation had been 
predicted earlier (23, 24), based on detailed analysis of the 
terminal stages of SV40 replication. 
Analysis of the yeast mutants uggests that topoisomerase 
II has a physiological role in regulating events at the chro- 
mosomal level. Our observation that the enzyme is a struc- 
tural component of the mitotic chromosome scaffold suggests 
that specific ultrastructural interactions might contribute sig- 
nificantly to regulation of the activity of topoisomerase II in 
vivo. 
Topoisomerase II Is a Structural Component of 
Chicken Chromosome Scaffolds 
Published ata on the composition of mitotic chromosome 
scaffolds indicate that the structures are composed of a well 
defined subset of chromosomal proteins (10, 14). The basis 
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of the co-fractionation f these components during scaffold 
preparation is currently unknown, although one likely expla- 
nation is that the proteins exhibit some association within 
intact chromosomes. Whether or not these proteins are assem- 
bled into a discrete scaffold substructure mains the subject 
of ongoing investigation. 
Because chromosome scaffolds contain the most insoluble 
proteins found associated with mitotic chromosomes, it is 
necessary todemonstrate that specific proteins that appear in 
scaffolds are bona fide chromosomal components and not 
insoluble contaminants of the scaffold fraction. Four inde- 
pendent arguments suggest that the association of topoisom- 
erase II with mitotic chromosomes and scaffolds results from 
high affinity interactions rather than random precipitation or 
adventitious binding. 
(a) Enzyme assays, immunofluorescence, andcell fraction- 
ation all indicate that topoisomerase I1 is an integral compo- 
nent of mitotic chromosomes. We find no evidence for a 
substantial cytoplasmic pool of the enzyme in interphase c lls. 
It has been suggested that certain scaffold components might 
be insoluble fragments of cytoskeleton that contaminate iso- 
lated chromosome fractions (10). Clearly, this objection does 
not apply to topoisomerase II. 
As expected, the enzyme occurs in interphase nuclei. Sur- 
prisingly, however, it s greatly reduced or absent from some 
cells. These cells were shown to have a Gj DNA content, and 
may no longer be cycling. That topoisomerase II is found 
only in cycling cells is supported by the observation that 
enzyme activity is difficult to detect in normal rat liver (43; 
Halligan and Liu, unpublished), but is readily detected in 
regenerating liver (43). 
(b) Results of high resolution localization of topoisomerase 
II in intact chromosomes suggest that the enzyme is located 
at the base of the radial chromatin loops (15). Both immu- 
nofluorescence and immunoelectron microscopy indicate that 
the enzyme occupies a restricted region around the axis of 
swollen chromosomes. In addition, structural alterations re- 
suiting from treatment of swollen chromosomes in solution 
with anti-topoisomerase II support he conclusion that the 
enzyme is not found in the radial chromatin loops. 
(c) The enzyme is found in chromosome scaffolds prepared 
in two different ways. These involve extraction of chromo- 
somes with 2 M NaCI or with a low ionic strength polyanion 
mixture. The conductivity of the latter is equivalent to 20 
mM NaC1 (14). Evidence presented elsewhere indicates that 
these two methods extract chromosomal proteins by different 
mechanisms. The polyanion extraction is inhibited by as little 
as 12 mM added NaCI (14). In addition, the morphology of 
scaffolds produced by these two procedures is extremely dif- 
ferent (14). Despite these differences, the protein composi- 
tions of both types of scaffolds are similar (10), and the percent 
recovery of topoisomerase II is identical for both procedures. 
(d) Topoisomerase II is recovered in scaffolds with high 
yield. In fact, 70% of the enzyme present in isolated meta- 
phase chromosomes is recovered in scaffolds. Therefore, iso- 
lation of the scaffold is an efficient procedure. Some of the 
material lost from scaffolds is presumably ost due to frag- 
mentation of the structures during extraction, and as a result, 
the 70% figure for topoisomerase II is probably an underes- 
timate. 
Our interpretation f the above results is that topoisomerase 
II is a bona fide structural component of mitotic hromosome 
scaffolds. Counter arguments hat the enzyme occurs in scaf- 
folds as a result of adventitious sticking (13, 44) are difficult 
to reconcile with our observation that the enzyme is recovered 
with high yield in scaffolds prepared at both low and high 
ionic strength (points c and d above). 
Comparison with Other Scaffold Proteins 
Comparison of the above results with those obtained for 
other scaffold proteins is difficult, since this report describes 
the first experimentally raised serum to recognize a major 
scaffold protein. One unrelated scaffold protein has been 
characterized in some detail, however, This is CENP-B, an 
80,000-mol-wt human centromere protein that is detected by 
autoimmune sera from certain patients with rheumatic dis- 
eases (29, 31). Both electron microscopy (14) and a combi- 
nation of immunoblotting and immunofluorescence using 
the autoimmune sera (3 l) indicate that centromere compo- 
nents are retained in chromosome scaffolds prepared by our 
methods. Analysis of immunoblots similar to those shown in 
Fig. 8 indicates that 61 _+ 13% of the CENP-B is retained in 
scaffolds (W. C. Earnshaw, unpublished observations). 
The same immunoblots show that CENP-A (a related cen- 
tromere protein of_Mr 17,000 [29]) is completely solubilized 
during the scaffold extraction procedure (3 l). CENP-A and 
CENP-B share antigenic determinants (29). Therefore, struc- 
turally related proteins localized in close proximity in the 
chromosome may differ greatly in their binding to the chro- 
mosome scaffold. This is further evidence that the protein 
composition of the scaffold fraction is determined by specific 
interactions. 
IS Human Sc-1 Topoisomerase I1? 
When the protein composition of human chromosome 
scaffolds was analyzed in detail, the structures were found to 
be significantly enriched in two polypeptide species, Sc-1 (Mr 
170,000) and Sc-2 (M, 135,000 [10, 14]). Wehave now shown 
that a chicken scaffold protein of Mr 170,000 is topoisomerase 
II. However, recent evidence suggests that human Sc-I is 
composed of at least hree co-migrating polypeptides. 
(a) Both chicken and human (W. C. Earnshaw, B. Halligan, 
M. M. Heck, and L. F. Liu, unpublished observations) chro- 
mosome scaffolds contain topoisomerase I1 as demonstrated 
by immunoblotting and immunofluorescence. 
(b) A second polypeptide of Mr 170,000 in humans is 
antigenically related to a chicken chromosomal ntigen of Mr 
135,000 (M. M. Heck and W. C. Earnshaw, manuscript in 
preparation). This antigen is not topoisomerase I1. 
(c) A third human chromosomal polypeptide ofMr 170,000, 
recognized by a human autoimmune s rum (W. C. Earnshaw 
and N. F. Rothfield, unpublished observations) is antigeni- 
cally related to a chicken chromosome protein of Mr 160,000. 
This species is also apparently not topoisomerase II, and is 
not recognized by our anti-cSc-1 serum. 
These results suggest hat human Sc-1 is composed of a 
mixture of polypeptides. Therefore any functional analysis of 
this species that relies solely on one-dimensional SDS PAGE 
must be interpreted with caution. 
Implications for the Organization of 
Interphase Nuclei 
While loop models provide a convenient framework for 
understanding the structure of mitotic chromosomes and 
interphase nuclei, most interest on chromatin domains centers 
on interphase, where the genome is physiologically active, 
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and where the structural organization is much less well char- 
acterized. Data consistent with the existence of chromatin 
loop domains in interphase cells has been obtained using 
several different techniques (16-22). These domains are sim- 
ilar in size to the radial loops observed irectly in swollen and 
dehistonized mitotic chromosomes (7, 14, 45). 
Our data suggest that the cell might use an enzymatic 
mechanism to control the topology of these loop domains. 
Previous workers have pointed out correlations between the 
size of loops in interphase chromatin and the size of both 
replicons and regions of intermediate DNase I sensitivity 
flanking actively transcribed genes (20, 46-48). The impor- 
tance of loop structures in transcription has long been known 
for the case of lampbrush chromosomes (49, 50). More re- 
cently, it was proposed that promoters might be activated or 
repressed through alterations in superhelicity (51, 52). Super- 
helicity might be controlled by alterations in the secondary 
structure of the DNA (53, 54), transient dissociation of nu- 
cleosomes from control regions (55), or by the action of an 
ATP-requiring eucaryotic DNA gyrase (as suggested by recent 
drug studies [56]). Although isolated eucaryotic type II topo- 
isomerases lack gyrase activity (25), the logical candidate for 
the putative gyrase in vivo remains topoisomerase II.
One role for topoisomerase II in vivo has been shown to be 
resolution of catenated loops that result from replication of 
closed circular DNA molecules. The enzyme is required for 
chromosome segregation in procaryotes (Escherichia coli 
[57]), viruses (SV40 [23, 24]), and lower eucaryotes (S. cere- 
visiae [26]; S. pombe [27]). 
The radial loop model of chromosome structure proposed 
that each chromosome consists of loops that are topologically 
fixed due to binding of scaffold proteins (6, 7, 10, 45). One 
efficient way of regulating the segregation of these domains 
after replication would be to make the enzyme required for 
decatenation (topoisomerase II) part of the framework re- 
sponsible for establishment and maintenance of the loop 
structure. Therefore, topoisomerase II would be expected to 
be a component of the insoluble "nuclear matrix" fraction 
prepared from interphase cells, That this is indeed the case 
has been demonstrated by the experiments of Berrios et al. 
(59) using antibody recognizing the Drosophila enzyme, and 
also by experiments from this laboratory using the rabbit anti- 
topoisomerase II antibody discussed above and nuclei pre- 
pared from Drosophila and rat (Halligan, B., D. Small, B. 
Vogelstein, T.-S. Hsieh, and L. F. Liu, manuscript submitted 
for publication). 
If topoisomerase II were part of the structural framework 
responsible for the loop organization of the chromatin of 
mitotic chromosomes, the enzyme would be expected to be 
concentrated at the base of the radial chromatin loops. Our 
data concerning the distribution of topoisomerase II in 
chicken mitotic hromosomes (15) are consistent with this 
model. 
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